BeiGene plans to rebrand as BeOne Medicines, reflecting a global focus and collaboration in oncology. The firm’s growing ...
Shares of German drug discovery company Evotec leapt 20% to 10.33 euros this morning on the revelation that the USA’s ...
Oxford, UK-based rare respiratory diseases focused AlveoGene today revealed it has been granted a Rare Pediatric Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback